Surgery is the definitive treatment for normocalcemic primary hyperparathyroidism with four-gland hyperplasia and severe neuromuscular symptoms
Given the presence of severe neuromuscular lower limb symptoms in the context of four-gland hyperplasia, this patient meets criteria for parathyroid surgery and should undergo bilateral neck exploration by an experienced parathyroid surgeon. 1, 2
Why Surgery is Indicated
The severe neuromuscular symptoms represent significant morbidity that warrants surgical intervention, even in normocalcemic disease. While neuromuscular manifestations are not explicitly listed in the formal surgical criteria, the 2025 French guidelines acknowledge that patients with cardiovascular and/or neurobehavioral manifestations should have their cases discussed in a multidisciplinary setting to assess the risk/benefit ratio of surgical intervention 2. Severe neuromuscular symptoms affecting quality of life and mobility clearly justify this discussion, and the presence of four-gland disease makes the diagnosis more definitive.
Critical Surgical Considerations for Four-Gland Disease
This case requires bilateral neck exploration with visualization of all four glands, not a minimally invasive approach. Here's why:
- Normocalcemic hyperparathyroidism has significantly higher rates of multiglandular disease (31% vs 18% in hypercalcemic disease) 3
- Four-gland hyperplasia requires subtotal parathyroidectomy (3.5 glands removed) or total parathyroidectomy with autotransplantation
- Intraoperative PTH monitoring is less reliable in normocalcemic disease, with lower positive predictive value (84.2% vs 95.7%) 3
- Cure rates are lower in normocalcemic patients (76-80.5% vs 95%) 3
Preoperative Imaging Expectations
Expect negative or non-localizing imaging studies. Normocalcemic patients have significantly more negative sestamibi scans (51.3% vs 8.2% in hypercalcemic disease) and smaller parathyroid glands (mean weight 436mg vs 742mg) 3. The nodules on all four glands may be visible on ultrasound, but nuclear medicine imaging may fail to localize. This should not deter surgery when symptoms are severe.
Postoperative Outcomes to Anticipate
Even if postoperative PTH remains mildly elevated (which occurs in 24% of normocalcemic patients), bone mineral density improvements still occur 4. Patients with persistent PTH elevation after surgery actually showed greater improvement in total hip bone density (3.73% vs -0.83%) compared to those who normalized PTH 4.
Alternative Only if Surgery Contraindicated
If this patient has absolute surgical contraindications (severe cardiopulmonary disease, refuses surgery after informed consent), then pharmacological management would include 1, 2:
- Cinacalcet if calcium rises >0.25 mmol/L above normal
- Bisphosphonates (alendronate) or denosumab for bone protection
- Vitamin D supplementation to target >30 ng/mL
- Calcium intake 800-1000 mg/day
However, medical therapy has never been shown to improve neuromuscular symptoms or quality of life 2, making it inadequate for this patient's severe lower limb symptoms.
Common Pitfalls to Avoid
- Do not attempt minimally invasive parathyroidectomy - four-gland disease requires bilateral exploration
- Do not rely solely on intraoperative PTH drop - it's less predictive in normocalcemic disease
- Do not defer surgery based on normal calcium - severe symptoms justify intervention regardless
- Do not consider local destruction techniques - these are only for patients truly ineligible for surgery and carry similar recurrent nerve injury risks 1
The surgeon must be experienced in four-gland exploration, as this is technically more demanding than single adenoma removal and has higher rates of requiring reoperation 5.